The active ingredient LYGALAMINE is the only one to have a triple action on skin aging with a better efficiency than certain reference molecules (for example Vitamin E).

About

Our patented anti-aging active was developed after 13 years of French biomedical research (CNRS, INSERM). 3 patents filed, including 1 international patent (operated exclusively by Pharm'Aging) were necessary to obtain the best efficiency for this active ingredient. The active ingredient LYGALAMINE is the only one to have a triple action on skin aging with a better efficiency than certain reference molecules (for example Vitamin E) with a concentration 100 to 1000 times lower. Our results have shown that your skin gains 50% more elasticity from the 9th day

Key Benefits

• Strong scientific and medical marketing thanks to Lygalamine: exclusive, innovative and globally patented active ingredient from French research laboratories (CNRS, INSERM). • Higher efficiency than certain reference molecules: more anti-oxidant efficiency compared to vitamin E for example. • Efficiency at low concentration: 100 to 1000 times less concentrated than other competitive active ingredients.

Applications

Thanks to its worldwide patented and exclusive anti-aging active ingredient, Lygalamine, Pharm’Aging provides manufacturers with technical innovation enabling them to increase their competitiveness and / or to differentiate themselves from other competing active ingredients.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations